[Fulvestrant].
Andersson
Michael
M
H:S Rigshospitalet, Finsencenter, Onkologisk Klinik, København. michael.andersson@dadlnet.dk
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D000077267:Fulvestrant; D006801:Humans
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D000077267:Fulvestrant; D004958:Estradiol